World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Vaccine Makers Enjoy Immunity
Keywords:
Tags: Pharmaceutical,
The National Childhood Vaccine Injury Compensation Program protects vaccine makers from much of the litigation risk faced by pharmaceutical manufacturers. It limits compensation for death to $250,000. This special vaccines court is called Office of Special Masters at the U.S. Court of Federal Claims. This may be one reason for Pfizer's willingness to pay $68 billion for Wyeth which is amaker of childhood vaccines. Vaccines will generate $21.5 billion in sales by 2012, according to Sanofi-Aventis. Vaccines are biologic products that can't be copied. Wyeth's Prevnar is designed to protect children against 7 strains of pneumococcal disease. It has sales of $2.7 billion projected to grow to $5.5 billion in 2015 according to Sanford C. Bernstein & Co. Vaccines have driven huge reductions in childhood diseases, and the Act is designed to potect makers of vaccines, who suffered from excessive litigation in the 1980's.
Paying for universal health coverage in the U.S.
04/18/2006
The Obama administration estimates it will cost about $120 billion to cover roughly 50 million uninsured. Everything from taxing high calorie sodas, limiting tax dedcuctions for charitable giving, or decuctions for employer provided health insurance, are all being looked at Some like limiting deductions on chartable giving lack support in Congress.
Grouped Articles
Health Battle Over Soda Flares in Mexico
Wall Street Journal 08/28/2013
Recession Swells Number of Uninsured to 50.7 Million
Wall Street Journal 09/17/2010
Exchanges See Little Progress on Uninsured
Wall Street Journal 01/20/2014
Wal-Mart Cuts Prices for Many Generic Drugs to $4 - WSJ.com
Wall Street Journal 09/22/2006
A J&J Copycat Could Extend Old Drug's Life - WSJ.com
Wall Street Journal 09/29/2006
As Patients, Doctors Feel Pinch, Insurer's CEO Makes a Billion - WSJ.com
Wall Street Journal 04/18/2006
The new attractiveness of vaccines for drug companies.
02/23/2009
Vaccines represent a steady stream of reliable revenues for drug companies. They are also in great demand in high growth emerging markets like Brazil and China and help form relationships in these countries.
Grouped Articles
Wall Street Journal 02/23/2009
U.S. Drug Companies Chase Vaccines
Wall Street Journal 09/29/2009
Vaccine Maker Pfizer and the National Childhood Vaccine Injury Compensation Program.
01/26/2009
The limits to litigation risk for vaccines is one reason for the attractiveness and growing investment in the vaccines development. Its also what Pfizer hopes to develop with the Wyeth acquisition for $68 billion.
Linked Articles
Wall Street Journal 02/23/2009
Pfizer Agrees to Pay $68 Billion for Rival Wyeth
New York Times 01/26/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us